Americans Spend More on Health Care, but Fare Worse

Share this content:
Americans Spend More on Health Care, but Fare Worse
Americans Spend More on Health Care, but Fare Worse

MONDAY, Oct. 12, 2015 (HealthDay News) -- When compared to 12 other industrialized nations, Americans spend more on health care services, but they fare worst in terms of life expectancy, according to recent findings from The Commonwealth Fund.

Because most of the information in the report is based on 2013 data, the results do not take into account the implementation of many of the major provisions of the Affordable Care Act, and by some measures, the United States did fare relatively well. For example, the nation's cancer death rate was near the bottom of a list that includes Australia, Canada, Denmark, France, Germany, Japan, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom. Since 1995 that rate has been falling faster in the United States than in other nations. On the other hand, when it comes to obesity rates and infant mortality, the United States did poorly compared to other nations.

The United States spends $9,086 per person per year on health care, according to the report. The second-highest health care spender, Switzerland, spent only $6,325 on each of its citizens annually. While American life expectancy maxed out at 78.8, the Swiss life expectancy is 82.9 years.

Although the United States was the only country on the list that doesn't have universal health care coverage, the U.S. government was nevertheless spending far more money on health care than other developed nations, the investigators found. For example, while the U.S. government spent almost $4,197 on health care per person (via Medicare and Medicaid) in 2013, the United Kingdom spent just $2,802 per person.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths